AU6194300A - An oral composition having as a first active ingredient rofleponide and as a second active ingredient an antibiotic, for use in intestinal conditions, especially crohn's disease - Google Patents

An oral composition having as a first active ingredient rofleponide and as a second active ingredient an antibiotic, for use in intestinal conditions, especially crohn's disease

Info

Publication number
AU6194300A
AU6194300A AU61943/00A AU6194300A AU6194300A AU 6194300 A AU6194300 A AU 6194300A AU 61943/00 A AU61943/00 A AU 61943/00A AU 6194300 A AU6194300 A AU 6194300A AU 6194300 A AU6194300 A AU 6194300A
Authority
AU
Australia
Prior art keywords
active ingredient
rofleponide
antibiotic
disease
oral composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU61943/00A
Inventor
Gunilla Nygard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of AU6194300A publication Critical patent/AU6194300A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU61943/00A 1999-07-12 2000-07-07 An oral composition having as a first active ingredient rofleponide and as a second active ingredient an antibiotic, for use in intestinal conditions, especially crohn's disease Abandoned AU6194300A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9902674 1999-07-12
SE9902674A SE9902674D0 (en) 1999-07-12 1999-07-12 New composition
PCT/SE2000/001469 WO2001003703A1 (en) 1999-07-12 2000-07-07 An oral composition having as a first active ingredient rofleponide and as a second active ingredient an antibiotic, for use in intestinal conditions, especially crohn's disease

Publications (1)

Publication Number Publication Date
AU6194300A true AU6194300A (en) 2001-01-30

Family

ID=20416478

Family Applications (1)

Application Number Title Priority Date Filing Date
AU61943/00A Abandoned AU6194300A (en) 1999-07-12 2000-07-07 An oral composition having as a first active ingredient rofleponide and as a second active ingredient an antibiotic, for use in intestinal conditions, especially crohn's disease

Country Status (3)

Country Link
AU (1) AU6194300A (en)
SE (1) SE9902674D0 (en)
WO (1) WO2001003703A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9704833D0 (en) * 1997-12-22 1997-12-22 Astra Ab New formulation

Also Published As

Publication number Publication date
WO2001003703A1 (en) 2001-01-18
SE9902674D0 (en) 1999-07-12

Similar Documents

Publication Publication Date Title
HUP0103341A3 (en) Azetidine derivatives, preparation and pharmaceutical compositions thereof
AU7429100A (en) Chondrocyte compositions, preparation and use thereof
IL172695A0 (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
AU3076700A (en) 2h-phthalazin-1-one derivatives and drugs comprising these derivatives as the active ingredient
PL345955A1 (en) PHARMACEUTICAL COMPOSITIONS AND USES FOR ANDROST-5-ENE-3β,17β-DIOL
HUP0203312A3 (en) Pharmaceutically active sulfonamide derivatives, process for their preparation, and pharmaceutical compositions and their use
AU5326100A (en) Pharmaceutical compositions and methods for use
MXPA02004349A (en) Pharmaceutical compositions containing a fluoroquinolone antibiotic drug and xanthan gum.
ZA200308221B (en) Pharmaceutical compositions for oral and topical administration.
AU1887401A (en) Medicinal composition
HRPK20010706B1 (en) Tolperison-containing, pharmaceutical preparation for oral administration
ZA200108001B (en) Processes for making pharmaceutical oral ECB formulations and compositions.
HUP0204154A3 (en) Novel benzothiadiazine derivatives, preparation method and pharmaceutical compositions containing same
CY2313B1 (en) Rapamycin formulations for oral administration.
HUP0203627A3 (en) N-guanidinoalkylamides, their preparation, their use, and pharmaceutical compositions comprising them
HUP0203903A3 (en) Solubilized pharmaceutical composition for parenteral administration and its use
AU1732401A (en) Medicinal compositions for oral use
ZA985095B (en) Rapamycin formulations for oral administration.
HUP0201810A3 (en) Sootepenseone and its derivatives, their preparation and use as medicament
AU6194300A (en) An oral composition having as a first active ingredient rofleponide and as a second active ingredient an antibiotic, for use in intestinal conditions, especially crohn's disease
NZ329271A (en) 4-benzyl-piperidin-4-ol derivatives, preparation and pharmaceutical compositions thereof
AU6194100A (en) An oral composition having as a first active ingredient budesonide and as a second active ingredient an antibiotic, for use in intestinal conditions, especiallycrohn's disease
AU1556601A (en) 1,3,4-oxadiazolin-2-one derivatives and drugs containing these derivatives as the active ingredient
AU2870899A (en) Oral formulation for hydrophilic drugs
AU6473699A (en) Aqueous drug formulation for oral application

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase